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A Salmonella enterica serovar Enteritidis epidemic in
the United States began in 1978, spread to much of the
country in the following decade, and began declining in
1996. We examined correlations between annual changes
in S. Enteritidis incidence in humans and introductions of
egg quality assurance programs (EQAPs) in some states to
reduce S. Enteritidis contamination of eggs. Before
EQAPs, 62% of the changes in S. Enteritidis incidence
were higher than the baseline for each state. After EQAPs,
73%–84% of the changes were below the baseline.
Regression analysis showed that a 1% increase in the
number of eggs produced under an EQAP was associated
with a 0.14% decrease in S. Enteritidis incidence (p < 0.05).
These data indicate that EQAPs probably played a major
role in reducing S. Enteritidis illness in these states. 
A
n epidemic of infections caused by Salmonella enter-
ica serovar Enteritidis in the United States began in
New England in 1978 and spread to much of the rest of the
country in the next decade. Though the spread has declined
in all regions since 1996 (Figure 1), the number and inci-
dence of S. Enteritidis infections have not shown substan-
tial decline since 1999 (1). Since grade A shell eggs have
been implicated as a major source of S. Enteritidis infec-
tions in humans in the United States (2), interventions have
been introduced to reduce S. Enteritidis infection in poul-
try and eggs and the resulting illness in humans (3–10).
These interventions include State Egg Quality Assurance
Programs (EQAPs), which are voluntary programs that are
based on Hazard Analysis Critical Control Point (HACCP)
principles and designed around production, management,
and monitoring practices to mitigate risk for S. Enteritidis
contamination of eggs (3,11,12). Motivations for egg
producers to adopt an EQAPmay include scientific, public
health, public relations, or marketing reasons (13).
Initially, producers enrolled voluntarily into state- or
industry-sponsored EQAPs. However, in some states,
commercial egg producers are required to participate in
EQAPs because egg processors, food commodity brokers,
insurance companies, and integrated commercial compa-
nies are increasingly demanding producer participation in
EQAPs as a condition of egg sales (12).
Research to date has focused on verifying the role and
effectiveness of EQAPs in mitigating S. Enteritidis in layer
flocks and eggs (4,5,13). Effectiveness might be indicated
by reductions of S. Enteritidis prevalence in layer flocks
(11,14,15), farm environments (11,16), and eggs produced
by infected flocks (5) after introducing EQAPs. Reported
reductions in S. Enteritidis rates in markets with EQAPs
have been used to explain the effectiveness of EQAPS in
reducing S. Enteritidis illness in humans (2,3,11,16,17).
Some evidence shows that interventions that reduce the
storage time of shell eggs, internal or ambient temperature,
or prevalence of S. Enteritidis–positive flocks or that
increase diversion of eggs from S. Enteritidis-positive
flocks to pasteurization, may help reduce the incidence of
S. Enteritidis in humans (18). However, little is known
about the contribution of each intervention to the overall
reduction in the number of S. Enteritidis cases. The present
study analyzes flock-based EQAPs to assess their actual
contribution to the reduction of S. Enteritidis incidence in
humans.
Methods
Baseline incidence was defined as S. Enteritidis inci-
dence in the year in which an EQAP was adopted in a state
or group of states affected by the S. Enteritidis epidemic.
We calculated S. Enteritidis incidence for a state or group
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USAof states as the number of reported human S. Enteritidis
isolates in a year divided by that state’s or group of states’
population for that year expressed per 100,000 persons.
We defined a state affected by the S. Enteritidis epidemic
as one for which the S. Enteritidis incidence was
>1/100,000 in any year between 1980 and 1999. 
States that adopted EQAPs were grouped into state- and
industry-sponsored EQAPs. We grouped EQAPs into
state-sponsored and industry-sponsored types on the basis
of whether the state government was actively involved in
third-party monitoring, supervision, provision of technical
advice, and procedure of handling houses that are found to
be  S. Enteritidis positive. In this study, state-sponsored
EQAPs were defined as having active state Department of
Agriculture and Department of Health involvement in pro-
viding technical advice, supervising and monitoring the
programs, requiring third-party auditing, testing eggs for
contamination with S. Enteritidis if houses were positive,
and diverting eggs found to be contaminated with S.
Enteritidis to pasteurization and hard cooking. Industry-
sponsored EQAPs were defined as lacking state govern-
ment involvement, recommending but not requiring
third-party audits of the program, and recommending
immediate extra cleaning of S. Enteritidis–contaminated
houses upon depopulation of the houses (19).
We calculated the percentage change in annual S.
Enteritidis incidence relative to the baseline (hereafter
referred to as the change in S. Enteritidis incidence):
We then divided the change in S. Enteritidis incidence
for a given year by the number of years before or after the
intervention to get the annualized percentage change in S.
Enteritidis incidence (hereafter referred to as the annual-
ized change in S. Enteritidis incidence). We used two
methods to examine changes in S. Enteritidis incidence: a
simple change-point procedure and regression analysis.
Change-point Analysis Framework
We constructed a graph with a horizontal axis repre-
senting time in years and a vertical axis representing S.
Enteritidis incidence (Figure 2A). If an intervention is
effective, S. Enteritidis incidence should decrease after the
baseline year (line b, Figure 2A). If the S. Enteritidis inci-
dence had been increasing before the intervention, a small-
er increase in incidence after the baseline would also show
evidence of effectiveness (line c, Figure 2A). If the S.
Enteritidis incidence had been decreasing before the inter-
vention, we would expect a faster decrease in incidence
after the baseline. Similarly, the lack of change in S.
Enteritidis incidence observed before, during, and after the
intervention would be evidence of lack of effect (line d,
Figure 2A), and an increase in S. Enteritidis incidence
(line e, Figure 2A) would be evidence that the intervention
was associated with an acceleration of the epidemic.
The effectiveness of an intervention can further be
assessed by using the annualized change in S. Enteritidis
incidence (Figure 2B). To show evidence of an interven-
tion’s effectiveness, we would expect the annualized
change in S. Enteritidis incidence after intervention to be
below the baseline rate (dotted line b, Figure 2B) or the
preintervention rate (dotted line b compared to a,
Figure 2B). A more modest effect after intervention that
shows the epidemic continuing to grow at a diminished
annualized rate would find the change in incidence above
baseline but below the preintervention level (dotted line c
compared to a, Figure 2B). An ineffective intervention
would result in an annualized change in S. Enteritidis inci-
dence after intervention that is equal to the rate before
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 10, October 2004 1783
Egg Quality Assurance Programs
(  ) 
on  introducti     EQAPs     of  year      t  for time,     T     ...,     1,     0,     T,...,-1,  -       t  state;  for     N     ...,     2,     1,  i    
  incidence;     SE  in     change  for     RI     incidence;     SE  for     stands     I       where,  , 
I 
I  I 
∆RI     (1) 
0 
it 
it  it 
it 
0 
0 
=  =  = 
∆ 
⎥ 
⎥ 
⎦ 
⎤ 
⎢ 
⎢ 
⎣ 
⎡  − 
= 
Figure 1. Reported isolates per 100,000 persons of Salmonella
enterica serovar Enteritidis by region, United States, 1970–1999.
(A) New England: Connecticut, Maine, New Hampshire, Rhode
Island, Vermont. (B) Mid-Atlantic: New Jersey, New York,
Pennsylvania. Pacific: Alaska, California, Hawaii, Oregon,
Washington. Mountain: Arizona, Colorado, Montana, Nevada, New
Mexico, Utah. Other states: Alabama, Arkansas, Delaware, Florida,
Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana,
Maryland, Michigan, Minnesota, Mississippi, Missouri, Nebraska,
North Carolina, North Dakota, Ohio, Oklahoma, South Carolina,
South Dakota, Tennessee, Texas, Virginia, Washington DC, West
Virginia, Wisconsin. Source: Centers for Disease Control and
Prevention, National Salmonella Surveillance System (1).
A
Bintervention (dotted line d compared to a, Figure 2B). An
annualized change in S. Enteritidis incidence above the
preintervention rate (line e compared to a, Figure 2B)
would be evidence that the intervention was associated with
an acceleration of the epidemic. If changes in S. Enteritidis
incidence continued at about the same rate or were sus-
tained for a number of years, the annualized change in S.
Enteritidis incidence would, in time, trend toward the base-
line. We calculated Yates corrected chi-square values to
verify whether changes in observations of annualized
S. Enteritidis incidence were statistically significant. 
We examined observations of pre-EQAP annualized
rates of change in S. Enteritidis incidence for a period of
up to 5 years and for a variable period of up to 8 years of
post-EQAP observations. The time periods selected were
considered to be long enough to include any relevant lag
effects and short enough to exclude confounding influence
of other interventions, such as those that require refrigerat-
ing eggs. To analyze the timing of the decrease in S.
Enteritidis incidence, we grouped states on the basis of
duration of postintervention follow-up and then type of
EQAP and compared the annualized changes in S.
Enteritidis incidence for each of the 5 years before adopt-
ing EQAPs and up to 5 years after adopting EQAPs. For
example, states that adopted EQAPs in 1996 had 3 years of
common experience with the intervention from 1996 to
1999 and formed a group based on this common length of
time. The annualized changes in S. Enteritidis provided a
measure for comparing incidence of S. Enteritidis before,
during, and after EQAP adoption.
Regression Model
We also examined the percentage change in S.
Enteritidis incidence by using a pooled regression model.
The pooling method can be used to combine cross-section
and time-series data. This technique allows for the error
terms to have equal variance on the chosen values of the
explanatory variables within a state, but unequal variance
between states (20–25), which results in efficient and unbi-
ased parameter estimates. We estimated a pooled regres-
sion equation for five cross-sectional states (Connecticut,
Louisiana, Indiana, Pennsylvania, and California) for 5
years post-EQAP by using SHAZAM (20). The pooled
regression equation was:
We included Louisiana in the regression model,
although it was unaffected by the epidemic, to improve the
degrees of freedom for the model. Only four of the states
that were affected by the S. Enteritidis epidemic had 5 years
of post-EQAP experience. Also, we included a dummy
variable in the model to control for states that were not
affected by the S. Enteritidis epidemic.
Independent variables (and types) were percentage of
eggs produced in participating farms (continuous), type of
EQAP (binary: state- or industry-sponsored: yes/no), num-
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Figure 2. A) Framework to compare Salmonella enterica serovar
Enteritidis incidence for a given year to the baseline incidence for
evidence of intervention effectiveness. Each arrow shows the
change of S. Enteritidis incidence for a given year, relative to base-
line incidence. The letter a shows increasing S. Enteritidis inci-
dence relative to the baseline incidence, b shows a reduction in S.
Enteritidis incidence relative to the baseline incidence, c shows a
smaller reduction, d shows no change, and e shows an increase.
B) Framework to compare annualized changes in S. Enteritidis
incidence for a given year to a baseline incidence for evidence of
effectiveness of an intervention. Each dot represents an annual-
ized change in S. Enteritidis incidence relative to the baseline
change in S. Enteritidis incidence, which is 0%. The letter a shows
preintervention annualized changes in S. Enteritidis incidence that
are above the baseline, indicating annual increase in incidence; b
shows postintervention annualized changes in S. Enteritidis inci-
dence that are below the baseline; and preintervention rates indi-
cating annual decrease in incidence; c are above baseline but
below preintervention rates; d are above baseline but equal to
preintervention rates; and e are above preintervention and base-
line rates. 
   .  error term     random     a  for     ε     and     ;  parameters 
unknown     of  number  for  K  1,2,...,     ;     ...,     ,     ,     parameters  unknown      the  of  vector 
column     X1  for        s;  y variable  explanator  for     X     incidence;     SE  in     change     percentage     the 
for     Y     for time,     T  1,...,    t  state;  for     stands     and     N  2...,     1,  i      where  ε  β 
 
X  Y     (2)    
it 
2  1 
it  it  it 
= 
=  =  +  = 
k 
k 
k  β  β  β 
β ber of United States Department of Agriculture (USDA) S.
Enteritidis outbreak traceback investigations (continuous),
proportion of population at high risk for S. Enteritidis (chil-
dren <5 years and seniors >65 years) (continuous), and
whether the state was in the northeast geographic region
(Connecticut, Pennsylvania, New York) (binary: yes/no).
The proportion of eggs produced under EQAPs by state and
year was the index to measure participation in EQAPs. 
Data Collection
We sent a detailed questionnaire to state veterinarians
and public health officials in all states that were involved
with S. Enteritidis control and prevention efforts. We also
asked state officials to share the questionnaire widely with
stakeholders (e.g., state departments of agriculture, labora-
tory workers, and egg industry officials) in state S.
Enteritidis mitigation efforts. 
The questionnaire collected data on whether egg pro-
ducers in the state had adopted an EQAP, and if so, the
type of EQAPto which most producers in the state adhered
(e.g., industry-or state-sponsored), year of EQAP initia-
tion, estimated proportion of total commercial layer-flock
participation in the EQAP by year, and elements of the
EQAP to which participants were required to adhere. The
annual number of S. Enteritidis cases was obtained from
reports by state and local health departments to the
National Salmonella Surveillance System (1). Estimates of
the annual population data for states were obtained from
the Bureau of the Census of the U.S. Department of
Commerce (26).
The annual numbers of eggs produced by state from
1972 to 1999 were obtained from USDA’s National
Agricultural Statistics Service (NASS) (27). To calculate
the proportion of eggs produced under an EQAP for each
state, we assumed no difference in egg production per
layer between layers raised under an EQAP and those
raised under no EQAP. We then calculated the proportion
of eggs produced under each EQAP as a product of the
proportion of total layer flocks that participated in the
EQAP and the annual total number of eggs produced by
each state. This calculation may overestimate the annual
total number of eggs produced for human consumption.
The category “table eggs” would provide a closer estimate
of eggs produced for human consumption. However, due
to confidentiality concerns, NASS does not publish com-
plete information on table egg production.
To estimate a proxy for the proportion of the state’s
population at high risk for S. Enteritidis, we used the resi-
dent population <5 years of age and >65 years of age and
total resident population. Data for estimates of the resident
population by age and state for 1989–1999 were obtained
from the U.S. Census Bureau (26). We obtained the num-
ber of successful S. Enteritidis outbreak traceback investi-
gations (investigation to establish origin of S.
Enteritidis–contaminated eggs) by state from USDA’s S.
Enteritidis Task Force Status Reports for 1990 to 1993 (8).
Similar information was not available for tracebacks from
1996 to 1999, when the Food and Drug Administration
was responsible for tracebacks. The typical procedure
when a traceback leads to farms is for the regulatory body
to take environmental samples of manure areas, egg belts
and escalators, fans, and feed. If the environment tests pos-
itive for S. Enteritidis, the farmer can either divert the eggs
to pasteurization or hard cooking for the lifetime of the
flock, divert the eggs until they test negative for S.
Enteritidis, or depopulate the flock.
Results
EQAP
Egg Production Under EQAP
We received analyzable results from 41 states. No
response was received from Idaho, Maine, Mississippi,
New Jersey, New Mexico, Virginia, Washington,
Wisconsin, or West Virginia. These states accounted for
≈9% of U.S. shell egg production from 1989 to 1999. State
officials in 15 of the 41 states reported that egg producers
in their respective states had adopted one of two kinds of
EQAPs from 1989 to 1999. Ten (Connecticut,
Pennsylvania, California, South Carolina, Maryland, Ohio,
Michigan, Utah, New York, Alabama) adopted state-spon-
sored EQAPs, and 5 (Louisiana, Indiana, Oregon, Florida,
Georgia) adopted industry-sponsored EQAPs. Eleven of
the 41 responding states were affected by the S. Enteritidis
epidemic, of which 9 had state-sponsored programs and 2
had industry-sponsored programs. The proportion of eggs
produced under EQAPs among the 41 responding states
increased from 1% in 1989 to 46% in 1999, and eggs pro-
duced under EQAPs among the 11 states that had EQAPs
and were affected by the S. Enteritidis epidemic increased
from 3% in 1989 to 79% in 1999 (Table 1). 
Change-point Analysis 
We calculated 55 preintervention and 40 postinterven-
tion annualized changes in S. Enteritidis incidence for 11
states that were affected by the S. Enteritidis epidemic and
adopted EQAPs (Table 2). Before adopting any EQAP
(state- or industry-sponsored), S. Enteritidis incidence rel-
ative to the baseline was higher in 62% of the observations
and lower in 38% of the observations (Figure 3). After
EQAPs were introduced, S. Enteritidis incidence increased
relative to the baseline in 28% of the post-EQAP observa-
tions and decreased in 73% of the observations, which
indicates a significant reduction (Yates-corrected chi-
square = 9.61, p = 0.0019). 
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adopted state-sponsored EQAPs, we calculated 45 prein-
tervention and 31 postintervention annualized changes
(Table 2). S. Enteritidis incidence was higher than the
baseline in 62% of the pre-EQAP observations and lower
in 38% of the observations (Figure 4). After the state-
sponsored EQAPs were introduced, S. Enteritidis inci-
dence increased relative to the baseline in 16% of the
observations and decreased in 84%, which indicates a sig-
nificant reduction (Yates-corrected chi-square = 14.05,
p = 0.00018). 
To analyze the timing of reductions in S. Enteritidis
incidence, we defined groups of 11, 7, 6, and 4 states with
at least 1 year, 2 years, 3 years, and 5 years of post-EQAP
follow-up, respectively. In each group, S. Enteritidis inci-
dence was increasing before adoption of EQAPs and
decreased afterwards. The effect of the intervention was
apparent in the first year and was sustained (Figure 5). 
Results of the Regression Model for States 
that Adopted EQAPs
Descriptive statistics for variables used in the regression
model are presented in Table 3. A 1% increase in the quan-
tity of eggs produced under an EQAP (state- or industry-
sponsored) was associated with a 0.14% (p < 0.05)
reduction in the change in S. Enteritidis incidence (Table 4).
Astate-sponsored EQAP was associated with a decrease of
72.25% (p < 0.1) in the change in S. Enteritidis incidence.
A 1% increase in the population at high risk for S.
Enteritidis was associated with an 8.15% (p < 0.05)
increase of the change in S. Enteritidis incidence. An
increase of 1 in the number of successful USDA S.
Enteritidis outbreak traceback investigations was associat-
ed with an increase of 2.82% (p < 0.001) in the change in
S. Enteritidis incidence. No significant associations were
found for changes in S. Enteritidis incidence and states
affected by the S. Enteritidis epidemic or located in the
Northeast region.
Discussion and Conclusions
Although a decline in prevalence of S. Enteritidis in
layer-flock eggs might indicate effectiveness of EQAPs in
mitigating  S. Enteritidis (4,6,10,12,16,28), a connection
with reductions of S. Enteritidis infections in humans is
necessary to indicate effectiveness of the programs in mit-
igating human illness. Our simple change-point procedure
showed a connection between the introduction of EQAPs
at the state level and significant reductions in S. Enteritidis
incidence in humans. The regression analysis found that
increasing the quantity of eggs produced under EQAPs
was associated with reducing S. Enteritidis incidence.
Several factors limited this study. Whether an EQAP
was introduced at the beginning of the year or at the end of
the year might make a difference, and defining a baseline
year might introduce error in the analysis. However, data
about the month in which EQAPs were introduced were
lacking for most states that adopted these programs.
Although some EQAPs are similar in that they were
designed through close collaboration among states,
they vary in practice and motivation, which limits
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sponsored. We found verifying the exact practices of each
EQAP to be difficult because EQAPs range from self-cer-
tification programs, like the 5-Star United Egg Producers
program (19) practiced in Indiana and Oregon that does
not require microbiologic testing for chicks, pullets, layers,
and eggs, to the more structured, regulated, rigorous, and
costly Pennsylvania Egg Quality Assurance Program (14).
Eleven of 15 states with EQAPs reported that they required
periodic sampling and testing of layer environments, lay-
ers, and eggs for S. Enteritidis, but 4 (Oregon, Louisiana,
Indiana, Georgia) did not. All states that required microbi-
ologic testing, except for Florida, involved their state gov-
ernments in setting up and monitoring their EQAP
programs. 
We did not study interactions in the regression model
because of few data points and degrees of freedom, which
limited the robustness of its results. We were more inter-
ested in the direction (positive or negative) of the estimate
of the percentage of eggs produced under EQAPs than the
magnitude. Also, our results were based on unverified
respondent estimates of the proportion of eggs produced
under EQAPs, information about the type of EQAP, and
when the EQAP was instituted. Further, because accurate-
ly estimating prevalence of diabetes, cancer, HIV/AIDS,
and pregnancy at the state level was difficult, we used the
population of children <5 years of age and seniors >65
years of age for each state to represent the population at
high risk for S. Enteritidis.
We assumed that eggs produced in a state are applied to
meet the consumption needs of that state, and changes in
S. Enteritidis incidence within the state would reflect the
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Figure 3. Observed annualized changes in Salmonella enterica
serovar Enteritidis incidence for 11 states that were affected by the
S. Enteritidis epidemic and adopted state- or industry sponsored
EQAPS. The 11 states were California, Connecticut, Indiana,
Maryland, Michigan, New York, Ohio, Oregon, Pennsylvania,
South Carolina, and Utah.
Figure 4. Observed annualized rates of change in Salmonella
enterica serovar Enteritidis incidence for nine states that were
affected by the S. Enteritidis epidemic and adopted state-
sponsored EQAPS. The nine states were California, Connecticut,
Maryland, Michigan, New York, Ohio, Pennsylvania, South
Carolina, and Utah.
Figure 5. Annualized change in Salmonella enterica serovar
Enteritidis incidence for groups of states that had egg quality
assurance programs (EQAPs) for the same period within group
and different periods among groups. The groups of states were 11
states with ≥1 year of post-EQAP follow-up (Connecticut, Indiana,
Pennsylvania, California, South Carolina, Maryland, Ohio,
Michigan, Utah, New York, Oregon), 7 states with ≥2 years of post-
EQAP follow-up (Connecticut, Indiana, Pennsylvania, California,
South Carolina, Maryland, Ohio), 6 states with ≥3 years of post-
EQAP follow-up (Connecticut, Indiana, Pennsylvania, California,
South Carolina, Maryland), and 4 states with ≥5 years of post-
EQAP follow-up (Connecticut, Indiana, Pennsylvania, California).effect of the state’s EQAP, but this assumption may not be
accurate. Eggs in the United States are distributed widely
across the nation through a dynamic system that makes it
difficult to track the source and destination of eggs by
state. Although data about the source and destination of
eggs and egg products are desirable, they are not currently
available (29). 
Not all egg producers immediately join EQAPs, and the
percentage of eggs produced in a state under an EQAP
varies as producers adopt or leave EQAPs. The simple
change-point analysis did not account for these variations
and assumed that EQAPs were homogeneous within and
among states. The regression model allowed EQAPs to be
homogeneous within states and heterogeneous among
states. 
Our model could not estimate unreported cases in a
meaningful way, although these cases constitute most
cases of salmonellosis (14). The larger proportion of S.
Enteritidis cases goes unreported (30). Other factors may
have affected S. Enteritidis incidence in humans that we
did not account for in this model because of lack of spe-
cific data, such as improvements in egg refrigeration dur-
ing distribution and handling, traceback investigations
from 1996 to 1999, and use of pasteurized eggs. However,
these measures were not implemented in tandem with the
EQAPs within or among states. Therefore, the close tem-
poral association between implementing EQAPs and
decreasing rates of S. Enteritidis infection indicate the
importance of EQAPs as a control strategy. 
The results of our study indicate that flock-based inter-
ventions have had a positive effect on health by reducing
S. Enteritidis incidence in humans. These data further indi-
cate that EQAPs probably played a major role in reducing
S. Enteritidis illness in the United States. Considering that
as of 1999, less than half of shell eggs in the United States
were produced under EQAPs (Table 1), and that the num-
ber of cases and relative rate of S. Enteritidis have not
shown significant decline since 1999, adopting EQAPS by
producers and states would likely improve the public’s
health and prevent reemergence of egg-based Salmonella.
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